Is a complete CSE/PHRX research report available?

Question

Accepted Answer

No complete published report is available for cse/PHRX (CSE/PHRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	671.1K
Net income (ttm)	-641.1K
EPS (ttm)	-CA$0.01
Shares out	134.2M
Volume	5,194
Beta	0.76

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 2.5M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	22.31
Isin	CA71716W2040
Last refreshed	2026-09-07
Market cap	CAD 671,072
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	5122
Symbol	cse/PHRX
Website	https://www.pharmadrug.ca

Metric	Value
Earnings Yield	-95.54%
FCF yield	-13.35%
P/B ratio	-0.39x

Metric	Value
Net Income	CAD -641,109
Net Income Growth Years	2%
ROA	-19.36
Roa5y	-18.85
ROCE	14.52
ROIC	-238.1

Metric	Value
Cagr1y	-50.02%
Cagr3y	-47.72%
Cagr5y	-57.25%
EPS Growth Years	2
Revenue Growth Years	0x

CSE/PHRX (CSE/PHRX)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/PHRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/PHRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/PHRX

Frequently asked questions

Metric	Value
Assets	CAD 752,217
Cash	CAD 23,060
Current Assets	CAD 48,253
Current Liabilities	CAD 2.2M
Debt	CAD 1.8M
Debt FCF	CAD -20.18
Equity	CAD -1.7M
Interest Coverage	-0.52
Liabilities	CAD 2.5M
Long Term Assets	CAD 703,964
Long Term Liabilities	CAD 291,100
Net Cash	CAD -1.8M
Net Cash By Market Cap	CAD -266
Tangible Book Value	CAD -2.3M
Tangible Book Value Per Share	CAD -0.02
WACC	14.91

Metric	Value
Current ratio	0.02
Net Working Capital	CAD -339,226
Quick ratio	0.02
Working Capital	CAD -2.1M

Metric	Value
1Y total return	-50%
200-day SMA	0.01
3Y total return	-85.71%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.57%
All Time High	4.55
All Time High Change	-99.89%
All Time High Date	2018-08-16
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-07-10
ATR	0
Beta	0.76
Beta1y	-2.21
Beta2y	-0.77
Ch YTD	-66.67
High	0.01
High52	0.03
High52 Date	2025-11-05
High52ch	-80%
Low	0.01
Low52	0.01
Low52 Date	2026-09-04
Low52ch	0%
Ma50ch	-43.82%
Price vs 200-day SMA	-57.63%
RSI	45.68
RSI Monthly	36.91
RSI Weekly	40.79
Sharpe ratio	1.87x
Sharpe Ratio3y	1.51x
Sharpe Ratio5y	1.15x
Sortino ratio	3.91
Sortino Ratio3y	3.06
Sortino Ratio5y	2.28
Total Return	-11.88%
Tr YTD	-66.67
Tr1m	-50%

Metric	Value
Float	106,854,380%
Net Borrowing	94,860
Shares Insiders	1.03%
Shares Out	134,214,380
Shares Qo Q	0%
Shares Yo Y	11.88%

Metric	Value
Average Volume	72,679.35x
Bv Per Share	-0.01
Ch1m	-50
Ch1y	-50
Ch3y	-85.71
Ch5y	-98.57
Ch6m	-66.67
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	50,244
Dollar Volume	25.97
Earnings Date	2026-11-27
EBIT	CAD -206,060
EBITDA	CAD -155,816
EPS	CAD -0.01
F Score	2
FCF	CAD -89,557
FCF EV Yield	-3.51x
FCF Per Share	CAD -0
Financing CF	94,860
Fiscal Year End	December
Founded	2,011
Is Primary Listing	1
Last Earnings Date	2025-11-03
Last Report Date	2026-06-30
Last Split Date	2023-10-24
Last Split Type	Reverse
Ma150	0.01
Ma150ch	-58.68%
Ma20	0.01
Ma20ch	-35.9%
Net CF	5,303
Next Earnings Date	2026-11-27
Open	0.01
Price Date	2026-09-04
Relative Volume	0.07x
Tr6m	-66.67%
Volume	5,194